脓毒症休克患者早期乳酸清除率与28天 全因病死率的相关性分析
Correlation Analysis between Early Lactate Clearance Rate and 28-Day All-Cause Mortality in Patients with Septic Shock
DOI: 10.12677/acm.2026.1641773, PDF,   
作者: 丹尼尔·赛德尔丁:新疆医科大学第六附属医院重症医学科,新疆 乌鲁木齐;艾孜买提·艾尼瓦尔*:新疆医科大学第六附属医院急诊科,新疆 乌鲁木齐
关键词: 脓毒症休克早期乳酸清除率28天全因病死率回顾性队列研究重症医学科Septic Shock Early Lactate Clearance Rate 28-Day All-Cause Mortality Retrospective Cohort Study Intensive Care Unit (ICU)
摘要: 目的:探讨新疆医科大学第六附属医院重症医学科(ICU)收治的脓毒症休克患者早期乳酸清除率与28天全因病死率的相关性,为临床评估患者预后、优化治疗策略提供参考依据。方法:回顾性收集2022年1月至2026年1月期间新疆医科大学第六附属医院ICU收治的脓毒症休克患者的临床资料,根据Sepsis-3定义筛选研究对象,排除不符合纳入标准、临床资料缺失及随访失败的患者。收集患者一般资料、入院时生命体征、实验室检查指标(入院时及入院6 h乳酸水平、血常规、肝肾功能、凝血功能等)、基础疾病、感染部位、治疗措施及28天生存情况。计算早期(6 h)乳酸清除率,根据乳酸清除率中位数将患者分为高乳酸清除率组(≥中位数)和低乳酸清除率组(<中位数),比较两组患者的临床特征及28天全因病死率。采用Kaplan-Meier法绘制生存曲线,Log-rank检验比较两组生存差异;采用单因素及多因素Logistic回归分析探讨脓毒症休克患者28天全因病死率的影响因素,重点分析早期乳酸清除率与28天全因病死率的相关性。结果:共纳入82例脓毒症休克患者,其中男性48例(58.5%),女性34例(41.5%),年龄(62.1 ± 15.9)岁。早期乳酸清除率中位数为26.8%,其中高乳酸清除率组41例(50.0%),低乳酸清除率组41例(50.0%)。低乳酸清除率组28天全因病死率(46.3%)显著高于高乳酸清除率组(24.4%),差异有统计学意义(P < 0.05)。Kaplan-Meier生存分析显示,高乳酸清除率组28天生存率显著高于低乳酸清除率组(Log-rank χ2 = 8.925, P < 0.01)。单因素分析显示,年龄、APACHEII评分、SOFA评分、入院时乳酸水平、早期乳酸清除率、感染性休克持续时间、机械通气时间、是否合并多器官功能障碍综合征(MODS)与脓毒症休克患者28天全因病死率相关(P均<0.05)。多因素Logistic回归分析显示,早期乳酸清除率降低(OR = 0.951, 95% CI: 0.926~0.977, P < 0.001)、APACHEII评分升高(OR = 1.102, 95% CI: 1.056~1.150, P < 0.001)、合并MODS (OR = 3.208, 95% CI: 1.672~6.156, P < 0.001)是脓毒症休克患者28天全因病死率的独立危险因素。结论:新疆医科大学第六附属医院ICU收治的脓毒症休克患者中,早期乳酸清除率与28天全因病死率密切相关,早期乳酸清除率降低提示患者预后不良,可作为评估脓毒症休克患者短期预后的重要临床指标,指导临床优化复苏治疗策略。
Abstract: Objective: To explore the correlation between early lactate clearance rate and 28-day all-cause mortality in patients with septic shock admitted to the Intensive Care Unit (ICU) of the Sixth Affiliated Hospital of Xinjiang Medical University, so as to provide a reference for clinical evaluation of patients’ prognosis and optimization of treatment strategies. Methods: The clinical data of patients with septic shock admitted to the ICU of the Sixth Affiliated Hospital of Xinjiang Medical University from January 2022 to January 2026 were retrospectively collected. Study subjects were screened according to the Sepsis-3 definition, and patients who did not meet the inclusion criteria, had missing clinical data or failed follow-up were excluded. General information, vital signs on admission, laboratory examination indicators (lactate levels on admission and 6 hours after admission, blood routine, liver and kidney function, coagulation function, etc.), underlying diseases, infection sites, treatment measures and 28-day survival status of the patients were collected. The early (6-hour) lactate clearance rate was calculated. Patients were divided into a high lactate clearance rate group (≥median) and a low lactate clearance rate group (χ2 = 8.925, P < 0.01). Univariate analysis showed that age, APACHEII score, SOFA score, lactate level on admission, early lactate clearance rate, duration of septic shock, duration of mechanical ventilation, and whether complicated with multiple organ dysfunction syndrome (MODS) were correlated with 28-day all-cause mortality in patients with septic shock (all P < 0.05). Multivariate Logistic regression analysis showed that decreased early lactate clearance rate (OR = 0.951, 95% CI: 0.926~0.977, P < 0.001), increased APACHEII score (OR = 1.102, 95% CI: 1.056~1.150, P < 0.001), and complicated with MODS (OR = 3.208, 95% CI: 1.672~6.156, P < 0.001) were independent risk factors for 28-day all-cause mortality in patients with septic shock. Conclusion: Among patients with septic shock admitted to the ICU of the Sixth Affiliated Hospital of Xinjiang Medical University, early lactate clearance rate is closely correlated with 28-day all-cause mortality. Decreased early lactate clearance rate indicates poor prognosis of patients, which can be used as an important clinical indicator to evaluate the short-term prognosis of patients with septic shock and guide clinical optimization of resuscitation treatment strategies.
文章引用:丹尼尔·赛德尔丁, 艾孜买提·艾尼瓦尔. 脓毒症休克患者早期乳酸清除率与28天 全因病死率的相关性分析[J]. 临床医学进展, 2026, 16(4): 5008-5016. https://doi.org/10.12677/acm.2026.1641773

参考文献

[1] Weiss, S.L., et al. (2026) Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026. Pediatric Critical Care Medicine, 1, 262-266.
[2] 张赫, 许晓蓉, 平江, 等. 超声心动图心脏变异度指标评估脓毒症休克患者容量反应性的价值[J]. 中国急救复苏与灾害医学杂志, 2026, 21(3): 369-373.
[3] Liu, J., Li, M., Xing, M., Liu, H., Wu, X., Wang, L., et al. (2026) Caspase-8-Mediated CYLD Cleavage Boosts LPS-Induced Endotoxic Shock. Cell Death & Differentiation. [Google Scholar] [CrossRef
[4] 储文梅, 王文清, 陈莉云, 等. 脓毒症患者血清Trx1、PDCD4表达及其与28 d生存情况的关系[J]. 疑难病杂志, 2026, 25(3): 280-284.
[5] Sun, A., Gao, X., Gao, Z., Zhang, Q. and He, W. (2026) Correction: Hydrocortisone Combined with Fludrocortisone for Treatment of Adults with Septic Shock: An Updated Meta-Analysis and Systematic Review. Frontiers in Medicine, 13, Article ID: 1811616. [Google Scholar] [CrossRef
[6] Tran, Q., Vanga, R., Borrisov, M., Hwang, S., Najafali, D., Walker, J., et al. (2026) 153: Outcomes of Epinephrine versus Dobutamine and Norepinephrine for Septic Shock and Cardiomyopathy. Critical Care Medicine, 54. [Google Scholar] [CrossRef
[7] 麻贤辉, 陈斌辉, 王鑫. 红细胞分布宽度与血小板计数比值在脓毒症性凝血病早期诊断中的效价研究[J]. 中国现代医生, 2025, 63(36): 41-45, 60.
[8] Armina-Rodriguez, A., Dorta-Estremera, S.M., Mendez, L.B. and Espino, A.M. (2026) Protection of Mice against Septic Shock Induced by Lethal Intraperitoneal Dose of LPS by a Recombinant fasciola Hepatica Fatty Acid Binding Protein. Microbiology Spectrum, 14, e02756-25. [Google Scholar] [CrossRef
[9] Negruț, M.F., Pastor, V., Bolcaș, R., Antal, O., Szabo, R. and Petrișor, C. (2026) Free Thyroxine as a Predictor of Mortality in Critically Ill Septic Patients—A Retrospective Study. Diagnostics, 16, Article No. 680. [Google Scholar] [CrossRef
[10] 赵浩, 张洁, 周学春, 等. 加味回阳升陷汤治疗脓毒症休克的临床疗效及对免疫炎症因子的影响[J]. 河北中医, 2026, 48(2): 242-245+251.
[11] 鲁琳娜, 王雨涵, 盛业东, 等. 钾钙离子通道介导脓毒性休克血管低反应性的研究进展[J/OL]. 医学研究杂志, 1-10.
https://link.cnki.net/urlid/11.5453.r.20260225.1057.002, 2026-03-25.
[12] Lee, C., Suh, G.J., Choi, S., Chung, S.P., Kim, W.Y., Lim, T.H., et al. (2026) Comparison of Prognosis in Emergency Department Elderly Septic Shock Patients with Initial Hypotension versus Delayed Hypotension. European Journal of Emergency Medicine. [Google Scholar] [CrossRef
[13] 刘彦锋, 王学朝. 血必净联合维生素C治疗脓毒症休克患者的效果观察[J]. 医学理论与实践, 2026, 39(4): 596-599.
[14] Wang, C., Leng, M., Sun, C., Cao, J., Li, L., Jia, Y., et al. (2026) Activated Platelet-Released Heat Shock Protein 90α Triggers Autophagy-Dependent Neutrophil Extracellular Trap Formation and Amplifies Sepsis. Advanced Science. [Google Scholar] [CrossRef
[15] Behaine, J.J.M., Mielke, A.R. and Ripoll, J.G. (2026) Venoarterial Extracorporeal Membrane Oxygenation and Seraph 100 for Meningococcemia Septic Shock and Purpura Fulminans. Journal of Cardiothoracic and Vascular Anesthesia. [Google Scholar] [CrossRef
[16] 王锡钦. 结合D-二聚体、FDP脓毒症休克患者近期预后的列线图预测模型构建[J]. 中国卫生工程学, 2026, 25(1): 128-130.
[17] Ebersole, B., Chu, J. and Durrani, M. (2026) Varicella-Zoster Virus Infection in an Immunocompromised Patient with Seizure-Like Activity and Septic Shock: A Case Report. Cureus, 18, e103835. [Google Scholar] [CrossRef
[18] 叶敏怡, 区杏莲, 彭志允. 脓毒症休克患者肠内营养中断预防的循证护理实践[J]. 安徽医学, 2026, 47(2): 241-247.
[19] Bashni T, M., Kothari, N., Sharma, A., Goyal, S., Sankanagoudar, S., Paliwal, B., et al. (2026) Effect of Neostigmine on Attenuation of Proinflammatory Cytokines When Given as an Adjuvant Therapy in Septic Shock: A Randomized Control Trial. Critical Care Medicine, 54, 904-914. [Google Scholar] [CrossRef
[20] 陈偲, 刘颖, 王晶晶, 等. 跨膜蛋白176B、白细胞介素-1β、白细胞介素-6及序贯器官衰竭评估评分对脓毒症及脓毒性休克患者早期预后的预测价值[J]. 实用临床医药杂志, 2026, 30(3): 69-73+80.
[21] Du, Y.W., Huang, T.J. and Zhang, P.Z. (2026) Application of Infrared Thermography in Early Screening of Sepsis and Prediction of Septic Shock Risk: A Systematic Review. Emergency Medicine International, 2026, Article ID: 1104018. [Google Scholar] [CrossRef
[22] 顾晓蕾, 庾胜, 龚菊, 等. 基于中心静脉-动脉血二氧化碳分压差及乳酸清除率的早期个体化液体复苏策略在脓毒性休克患者中的疗效研究[J]. 临床急诊杂志, 2024, 25(7): 343-347.
[23] 王俊峰, 季明霞, 何建新. 6小时血乳酸及乳酸清除率对心源性休克早期死亡的预测价值[J]. 实用休克杂志(中英文), 2024, 8(2): 98-103.